| Ia | immune response gene-associated antigen |
|---|---|
| IEG | immediate early gene |
| Ir | immune response [gene]; iridium |
| LAG | labiogingival; leukocyte antigen group; linguo-axiogingival; lymphangiogram; lymphocyte activation g... |
| MCC | mean corpuscular hemoglobin concentration; medial cell column; Medical Council of Canada; metacerebr... |
| dried human albumin | A sterile preparation of serum albumin obtained by fractionating blood plasma proteins from healthy persons; used as a transfusion material and to treat oedema due to hypoproteinaemia. Synonym: dried human albumin. (05 Mar 2000) |
|---|---|
| dried human plasma protein fraction | Freeze-dried human plasma protein fraction. (05 Mar 2000) |
| dried human serum | Serum prepared by drying liquid human serum by freeze-drying or by any other method that will avoid denaturation of the proteins and will yield a product readily soluble in a quantity of water equal to the volume of liquid human serum from which it was prepared. (05 Mar 2000) |
| influenza a virus, human | Strains of influenza a virus causing influenza and sometimes pneumonia in humans. Transmission is by aerosol. (12 Dec 1998) |
| iodinated 131I human serum albumin | A sterile, buffered, isotonic solution prepared to contain not less than 10 mg of radioiodinated normal human serum albumin per ml, and adjusted to provide not more than 1 mCi of radioactivity per ml; used as a diagnostic aid in the measurement of blood volume and cardiac output. (05 Mar 2000) |
| enteric cytopathogenic human orphan virus | eCHO virus |
| united states dept. Of health and human services | A department of the united states government concerned with administering those agencies and offices having programs pertaining to health and human services. (12 Dec 1998) |
| forefoot, human | The forepart of the foot including the metatarsals and the toes. (12 Dec 1998) |
| liquid human serum | The pool of fluids separated from blood withdrawn from human subjects and allowed to clot in the absence of any anticoagulant; not more than 10 separate donations are pooled; the contributions from donors of A, O, and either B or AB groups are represented in approximately the ratio 9:9:2. (05 Mar 2000) |
| allelic gene | See: allele, dominance of traits. (05 Mar 2000) |
| antibiotic resistance gene | Genes in a microorganism which confer resistance to antibiotics, for example by coding for enzymes which destroy it, by coding for surface proteins which prevent it from entering the microorganism, or by being a mutant form of the antibiotic's target so that it can ignore it. (09 Oct 1997) |
| autosomal gene | A gene located on any chromosome other than the sex chromosomes (X or Y). (05 Mar 2000) |
| bicoid gene | A group of genes which are important to the proper development of the head and thorax in the embryo of the fruit fly Drosophila melanogaster. (09 Oct 1997) |
| BRCA1 breast cancer susceptibility gene | This mutated (changed) version of the BRCA1 gene makes a person susceptible to developing breast cancer. (12 Dec 1998) |
| calcitonin gene-related peptide | <protein> A second product transcribed from the calcitonin gene. Calcitonin gene related peptide is found in a number of tissues including nervous tissue. It is a vasodilator that may participate in the cutaneous triple response. It is a neuropeptide of 37 amino acids with structural homology to salmon calcitonin. Co-localises with substance P in neurons. It occurs as a result of alternative processing of mRNA from the calcitonin gene. The neuropeptide is widely distributed in neural tissue of the brain, gut, perivascular nerves, and other tissue. The peptide produces multiple biological effects and has both circulatory and neurotransmitter modes of action. In particular, it is a potent endogenous vasodilator. Intracerebral administration leads to a rise in noradrenergic sympathetic outflow, a rise in blood pressure and a fall in gastric secretion. Acronym: CGRP (05 May 2002) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|